Source 42009009

What this page is, and is not

This is provisional, machine-derived output — not a graded claim, not a recommendation, and not a safety assessment. Human review of the underlying source is not yet complete.

Source kind: pubmed_abstract
Correction status: current
Review status: Assigned — pending review — Source registered and assignment complete. Dual human review, adjudication (if disagreement is found), and final lock are pending.
Source link: https://pubmed.ncbi.nlm.nih.gov/42009009/
Title: Safety and efficacy of individualised exercise and NAD(+) precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.
Journal: The Lancet. Neurology
Year: 2026
Topics (deterministic extraction): safety, efficacy, individualised, exercise, precursor, supplementation, patients, friedreich
Study attributes (deterministic extraction): randomized_controlled_trial
Machine indexing summary (provisional): [machine-generated structural index — no abstract excerpt; human review pending] Detected topic terms: safety, efficacy, individualised, exercise, precursor, supplementation, patients, friedreich. Detected study design: randomized_controlled_trial.
Processing status: processed

Authority (provisional)

Lane: provisional
Pending human review: true
Eligible for discovery: true
Eligible for topic summary: true
Claim grading eligible: false
Recommendations eligible: false
Safety gates eligible: false